Ajayi Samuel O, Ekrikpo Udeme E, Ekanem Anyiekere M, Raji Yemi R, Ogah Okechukwu S, Ojji Dike B, Okpechi-Samuel Ugochi S, Ndlovu Kwazi C Z, Bello Aminu K, Okpechi Ikechi G
Department of Medicine, College of Medicine, University of Ibadan, Ibadan, Oyo State, Nigeria.
Division of Nephrology and Hypertension, University of Cape Town, Cape Town, South Africa.
Int J Hypertens. 2021 Oct 11;2021:7243523. doi: 10.1155/2021/7243523. eCollection 2021.
Hypertension is a major global cause of cardiovascular disease and death with rising worldwide prevalence, particularly in low-income countries. With low awareness, poor treatment, and low control of hypertension in Africans, there is an increased number of patients with target organ damage (TOD), especially chronic kidney disease (CKD), as a consequence of hypertension. The aim of our study is to assess the prevalence of CKD from studies in Africa reporting TOD related to hypertension.
We performed a search of PubMed/MEDLINE, Web of Science, EBSCOhost, and African Journals Online (AJOL) for studies reporting on CKD as TOD in patients with hypertension. The pooled estimate of CKD was then presented by subregions, age group, eGFR equations, and urban or rural location.
We identified 1,334 articles from which 12 studies were included for quantitative analysis. The studies included 5297 participants from 6 countries (Ghana, Nigeria, Uganda, Tanzania, Democratic Republic of Congo, and South Africa). The pooled prevalence of CKD was 17.8% (95% CI 13.0-23.3%), and CKD was significantly more prevalent in West Africa (21.3% (95% CI: 16.1-27.0); < 0.0001) and in studies conducted in urban settings ( < 0.001). CKD prevalence was not significantly different by type of GFR equation or age.
This study reports a high prevalence of CKD related to hypertension with a higher prevalence in urban than rural areas. This emphasizes the role of hypertension in causing kidney damage, and the need for strategies to improve awareness, treatment, and control of hypertension in Africans. This study is registered with PROSPERO registration number CRD42018089263.
高血压是全球心血管疾病和死亡的主要原因,其在全球的患病率不断上升,尤其是在低收入国家。由于非洲人对高血压的知晓率低、治疗效果差且控制率低,高血压导致的靶器官损害(TOD)患者数量增加,尤其是慢性肾脏病(CKD)患者。我们研究的目的是通过非洲地区报告的与高血压相关的TOD研究来评估CKD的患病率。
我们在PubMed/MEDLINE、科学网、EBSCOhost和非洲在线期刊(AJOL)上搜索了关于高血压患者中CKD作为TOD的研究报告。然后按次区域、年龄组、估算肾小球滤过率(eGFR)方程以及城市或农村地区呈现CKD的合并估计值。
我们识别出1334篇文章,其中12项研究纳入定量分析。这些研究包括来自6个国家(加纳、尼日利亚、乌干达、坦桑尼亚、刚果民主共和国和南非)的5297名参与者。CKD的合并患病率为17.8%(95%置信区间13.0 - 23.3%),在西非地区(21.3%(95%置信区间:16.1 - 27.0);P < 0.0001)以及城市地区开展的研究中(P < 0.001),CKD的患病率显著更高。CKD患病率在GFR方程类型或年龄方面无显著差异。
本研究报告了与高血压相关的CKD的高患病率,城市地区高于农村地区。这强调了高血压在导致肾脏损害中的作用,以及在非洲改善高血压知晓率、治疗和控制策略的必要性。本研究在国际前瞻性系统评价注册库(PROSPERO)注册,注册号为CRD42018089263。